Today's biggest pre-market stock movers: MYNZ, IO, BBIG and more
Today's biggest pre-market stock movers: MYNZ, IO, BBIG and more
Gainers
赢家
$Mainz Biomed(MYNZ.US)$ rose 21.7% to $25.40 in pre-market trading after jumping 27% on Friday.
$ION Geophysical(IO.US)$ shares rose 21.18% to $1.03 in pre-market trading after the company reported forbearance and amendment related to its revolving credit agreement, forbearance agreement related to its senior secured second priority notes due 2025. The company also reported preliminary Q4 revenues of $40 million, representing a 45% year-over-year surge.
$Surgalign(SRGA.US)$ shares rose 26.48% to $1.08 in pre-market trading. Surgalign Holdings recently acquired 'significant equity interest' in Intenural Networks.
$Vinco Ventures(BBIG.US)$ rose 11.79% to $4.52 in pre-market trading following a 15% surge on Friday.
$Pluristem Therapeutics(PSTI.US)$ rose 8.81% to $2.10 in pre-market trading after jumping 10% on Friday. Pluristem Therapeutics and Tnuva recently announced a collaboration to establish a cultured food platform.
$Avinger(AVGR.US)$ rose 8.95% to $0.33 in pre-market trading. Avinger recently reported closing of $7.6 million registered direct offering.
$美因茨·比耶德(MYNZ.US)$在盘前交易中上涨21.7%，至25.40美元，上周五跃升27%。
$ION地球物理(IO.US)$在盘前交易中，该公司股价上涨21.18%，至1.03美元，此前该公司报告了与其循环信贷协议相关的忍耐和修订，即与2025年到期的优先担保第二优先票据相关的忍耐协议。该公司还公布了第四季度的初步收入为4,000万美元，同比增长45%。
$Surgalign(SRGA.US)$在盘前交易中，该公司股价上涨26.48%，至1.08美元。Surgalign Holdings最近收购了Intenial Networks的“重大股权”。
$Vinco Ventures(BBIG.US)$继上周五飙升15%后，该股在盘前交易中上涨11.79%，至4.52美元。
$Pluristem Treateutics(PSTI.US)$在盘前交易中上涨8.81%，至2.10美元，上周五跃升10%。Pluristem Treateutics和Tnuva最近宣布合作建立一个培养食品平台。
$Avinger(AVGR.US)$在盘前交易中，该股上涨8.95%，至0.33美元。Avinger最近报告称，已完成760万美元的注册直接发行。
Losers
失败者
$China SXT Pharmaceuticals(SXTC.US)$ shares fell 57.2% to $0.23 in pre-market trading after the company reported a proposed underwritten public offering of ordinary shares and pre-funded warrants to purchase ordinary shares.
$Splash Beverage(SBEV.US)$ shares fell 21.29% to $3.29 in pre-market trading after jumping around 119% on Friday.
$Molecular(MOLN.US)$ shares fell 14.46% to $27.28 in pre-market trading. Molecular Partners finalized license agreement with Novartis for Ensovibep for COVID-19.
$vTv Therapeutics(VTVT.US)$ fell 10.1% to $0.79 in pre-market trading.
$Unilever(UL.US)$ fell 9.9% to $48.96 in pre-market trading. GlaxoSmithKline received three proposals from Unilever for its Consumer business. However, Glaxo rejected all three offers from the company.
$Mechel PAO(MTL.US)$ shares fell 10.76% to $2.82 in pre-market trading.
$Camber Energy(CEI.US)$ shares fell 6.6% to $0.69 in pre-market trading. Camber Energy recently received a letter from the NYSE American.
$苏轩堂(SXTC.US)$在盘前交易中，该公司股价下跌57.2%，至0.23美元，此前该公司公布了一项拟议的普通股和预筹资权证公开发行计划，以购买普通股。
$Splash Beverage(SBEV.US)$股价在盘前交易中下跌21.29%，至3.29美元，上周五跃升约119%。
$分子(MOLN.US)$在盘前交易中，该公司股价下跌14.46%，至27.28美元。分子合作伙伴公司与诺华公司敲定了恩索维贝普用于新冠肺炎的许可协议。
$VTV Treeutics(VTVT.US)$在盘前交易中，该股下跌10.1%，至0.79美元。
$联合利华(UL.US)$在盘前交易中，该股下跌9.9%，至48.96美元。葛兰素史克收到了联合利华对其消费者业务的三份提案。然而，葛兰素史克拒绝了该公司的所有三项收购要约。
$鲍康如(MTL.US)$在盘前交易中，该公司股价下跌10.76%，至2.82美元。
$Camber Energy(CEI.US)$在盘前交易中，该公司股价下跌6.6%，至0.69美元。Camber Energy最近收到了纽约证券交易所美国人的一封信。